Alnylam Pharmaceuticals | Kostnadene For Salg

Cost Of Sales Endring Dato
Acadia Pharmaceuticals USD 22.95M 5.06M 2024-03
Agios Pharmaceuticals USD 627K 41K 2024-03
Alnylam Pharmaceuticals USD 65.98M 19.88M 2024-03
Amgen USD 3.2B 88M 2024-03
BioMarin Pharmaceutical USD 125.18M 10.3M 2024-03
Incyte USD 61M 3.05M 2024-03
Ionis Pharmaceuticals USD 2.15M 911K 2024-03
Moderna USD 96M 833M 2024-03
Neurocrine Biosciences USD 7.5M 3.7M 2024-03
Novartis USD 3.1B 109M 2024-03
PTC Therapeutics USD 14.74M 14.38M 2024-03
Regeneron Pharmaceuticals USD 433.8M 83.2M 2024-03
Sanofi EUR 3.44B 402M 2024-03
Sarepta Therapeutics USD 50.56M 13.53M 2024-03
Takeda JPY 379.48B 35.9B 2023-12
Ultragenyx Pharmaceutical USD 17.53M 5.48M 2024-03
Vertex Pharmaceuticals USD 342.6M 23.9M 2024-03



Alnylam Pharmaceuticals Kostnadene For Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.